//honeypot demagogic

 Forum DhammaCitta. Forum Diskusi Buddhis Indonesia

Author Topic: Calico: Googles ambitious new project to stop illnes and aging (immortal life?)  (Read 1469 times)

0 Members and 1 Guest are viewing this topic.

Offline kullatiro

  • Sebelumnya: Daimond
  • KalyanaMitta
  • *****
  • Posts: 6.155
  • Reputasi: 97
  • Gender: Male
  • Ehmm, Selamat mencapai Nibbana


http://gizmodo.com/calico-google-s-ambitious-new-project-to-stop-illness-1341933412

Google just announced its most recent plan in a long list of crazy moonshots. This one isn't self-driving cars or internet in the sky, instead it's a company called Calico that's going to try and put an end to aging and disease.

There aren't too many details about exactly how Calico will go about its business, but the plan is to make long-term bets that healthcare companies are generally pretty slow about. Calico will be run by Arthur D. Levinson, Chairman and former CEO of Genentech and Chairman of Apple, but he's not giving up his day job.

Larry Page summed up the project this way in a statement:

    Illness and aging affect all our families. With some longer term, moonshot thinking around healthcare and biotechnology, I believe we can improve millions of lives. It’s impossible to imagine anyone better than Art—one of the leading scientists, entrepreneurs and CEOs of our generation—to take this new venture forward.

This project has a lot less to do with Google's specific technical chops than the vast majority of Google's other moonshot projects. But Google does have scads of cash, which will be its main contribution. It seems that Calico will operate mostly on its own, and big money for an ambitious, independent project seems like as good a recipe for success as any.

Naturally it'll be a long time before we see this pay off in any way. Here's to hoping we get to see some results in a short decade or two. You know, before it's too late for us

Quote
Google announces Calico, a new company focused on health and well-being
MOUNTAIN VIEW, CA – September 18, 2013 – Google today announced Calico, a new company that will focus on health and well-being, in particular the challenge of aging and associated diseases. Arthur D. Levinson, Chairman and former CEO of Genentech and Chairman of Apple, will be Chief Executive Officer and a founding investor.

Announcing this new investment, Larry Page, Google CEO said: “Illness and aging affect all our families. With some longer term, moonshot thinking around healthcare and biotechnology, I believe we can improve millions of lives. It’s impossible to imagine anyone better than Art—one of the leading scientists, entrepreneurs and CEOs of our generation—to take this new venture forward.” Art said: “I’ve devoted much of my life to science and technology, with the goal of improving human health. Larry’s focus on outsized improvements has inspired me, and I’m tremendously excited about what’s next.”

Art Levinson will remain Chairman of Genentech and a director of Hoffmann-La Roche, as well as Chairman of Apple.

Commenting on Art’s new role, Franz Humer, Chairman of Hoffmann-La Roche, said: “Art’s track record at Genentech has been exemplary, and we see an interesting potential for our companies to work together going forward. We’re delighted he’ll stay on our board.”

Tim Cook, Chief Executive Officer of Apple, said: “For too many of our friends and family, life has been cut short or the quality of their life is too often lacking. Art is one of the crazy ones who thinks it doesn’t have to be this way. There is no one better suited to lead this mission and I am excited to see the results.”
Contact
Leslie Miller
Google Corporate Communications
press [at] google.com


http://googlepress.blogspot.com/2013/09/calico-announcement.html


http://content.time.com/time/magazine/article/0,9171,2152422,00.html
« Last Edit: 19 September 2013, 09:27:14 PM by kullatiro »

Offline kullatiro

  • Sebelumnya: Daimond
  • KalyanaMitta
  • *****
  • Posts: 6.155
  • Reputasi: 97
  • Gender: Male
  • Ehmm, Selamat mencapai Nibbana
Immortal worms, Telomeres & celular clean up
« Reply #1 on: 20 September 2013, 01:03:54 PM »
Immortal Worms, Telomeres & Cellular Clean Up

It may surprise you, but in the race to immortality, humans are in second place. But who is this agile and fleet-footed creature out- distancing we ever-powerful humans, you ask?
Why that would be none other than the noble Planarian Worm. Yes, in 2012, scientists from the University of Nottingham found a species of Planarian worm that could perpetually heal itslef
and divide.

“Usually when stem cells divide — to heal wounds, or during reproduction or for growth — they start to show signs of aging. This means that the stem cells are no longer able to divide and so become
less able to replace exhausted specialized cells in the tissues of our bodies,” explained researcher Aziz Aboobaker. “Our aging skin is perhaps the most visible example of this effect. Planarian worms and their stem cells are somehow able to avoid the aging process and to keep their cells dividing.”
Cross-section of a Planarian Flatworm. Photo from The School of Molecular and Cellular Biology at the University of Illinois
Essentially, one of the keys to immortality lies in Telomeres — which are essentially a region of nucleotide sequences that act as a protective cap, deterring the degradation of genes near the end of chromosomes by allowing their ends to shorten. Huh? In other words, as Science Daily points out, the Telomere is like the protective plastic cap at the end of your shoelace; each time a cell divides, the Telomere protects it from fraying or going on a 5-day bender. However, each time it does divide, your Telomere caps are reduced.
Theoretically, then, if someone can figure out a way to preserve or elongate these Telomeres, then we would be one step closer to a veritable genetic fountain of youth. Unfortunately, however, the science is still scant. Back in 1996, team of Nobel Prize-winning scientists explained that “telomere length is clearly not directly correlated with
organismal aging” [PDF].
However, Elizabeth Blackburn, Carol Greider and Jack Szostak won the Nobel Price for Physiology and Medicine in 2009 for their work, which found that telomere length could potentially be
maintained by catalyzing the activity of an enzyme known as “telomerase.” However, as Science Daily points out, in most organisms, the enzyme is really only turned on during those early developmental years. Planarian worms have managed to outfox this, and by studying the mechanics of their division and how they protect against degradation, Google Calico and anyone else for that matter could be on the right track.

Human Chromosomes capped by telomeres. Photo courtesy of U.S Department of Energy’s Human Genome Program Of course, again, real progress in longevity research requires time and money. Organizations and companies have been trying to tackle this problem for years, and many have been rebuffed.
For example, in 2008, pharma giant
GlaxoSmithKline shelled out $720 million for a promising drug, SRT501, a modified version of substance found in red wine that has been linked to anti-aging. Two years later, Glaxo gave up. But that was five years ago, and this is the company that managed to map the entire planet
in a few years. It’s hard to imagine Google will be pumping much money into Calico at first, but if it does, it could make a real difference. For now, sources tell us that Calico will primarily function as an R&D group, exploring the latest in longevity
science. However, it won’t rule out the possibility of manufacturing their own products down the line.

http://m.techcrunch.com/2013/09/19/wtf-is-calico-and-why-does-google-think-its-mysterious-new-company-can-defy-aging/?icid=tc_home_art&

 

anything